Humira combined with Paxil

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Coronary Artery Disease Hospitalization 12/1/2005 Male 5/25/2006 Physician United States
Primary
Concomitant
Lymphadenopathy 7/12/2006 Male 213 lb 12/13/2006 Other Health Professional United States
Primary
Concomitant
Weight Increased Female 8/9/2007 Consumer United States
Primary
Secondary
Concomitant
Weight Increased 7/1/2007 56 Male 245 lb 2/7/2008 Consumer United States
Primary
Secondary
Concomitant
Vitreous Haemorrhage Other Serious 1/1/1998 Male 4/14/2008 Lawyer United States
Primary
Secondary
Concomitant
Vitreous Haemorrhage Other Serious 1/1/1998 Male 6/9/2008 Other Health Professional United States
Primary
Secondary
Concomitant
Vitreous Haemorrhage Other Serious 1/1/1998 Male 6/18/2008 Other Health Professional United States
Primary
Secondary
Concomitant
Death Hospitalization 6/8/2008 Male 141 lb 7/18/2008 Physician United States
Primary
Concomitant
Death Hospitalization 6/8/2008 Male 141 lb 7/24/2008 Physician United States
Primary
Concomitant
Balance Disorder 6/1/2007 70 Male 8/5/2008 Consumer United States
Primary
Concomitant
Vitreous Haemorrhage Other Serious 1/1/1998 Male 10/10/2008 Other Health Professional United States
Primary
Secondary
Concomitant
Vitreous Haemorrhage Other Serious 1/1/1998 Male 11/4/2008 Other Health Professional United States
Primary
Secondary
Concomitant
Sinus Operation Other Serious 11/3/2008 Female 150 lb 12/22/2008 Consumer United States
Primary
Concomitant
Vomiting Other Serious 12/2/2008 Female 114 lb 12/22/2008 Canada
Primary
Concomitant
Sinus Operation Other Serious 11/3/2008 Female 150 lb 12/26/2008 Consumer United States
Primary
Concomitant
Suicide Attempt Life Threatening 12/31/2008 Female 150 lb 1/20/2009 Canada
Primary
Secondary
Concomitant
White Blood Cell Count Increased Hospitalization 1/1/2009 Female 190 lb 2/12/2009 Consumer United States
Primary
Concomitant
Suicide Attempt Life Threatening 12/31/2008 Female 150 lb 2/23/2009 Canada
Primary
Secondary
Concomitant
Tuberculin Test Positive Hospitalization 1/26/2008 Female 175 lb 2/27/2009
Primary
Concomitant
Vertigo 1/1/2004 Male 255 lb 3/13/2009 Consumer United States
Primary
Concomitant
Pain In Extremity 9/1/2008 Male 233 lb 3/14/2009 United States
Primary
Concomitant
Injection Site Pain Male 182 lb 3/14/2009 Consumer United States
Primary
Concomitant
Pain 1/1/2008 Male 190 lb 3/14/2009 Consumer United States
Primary
Concomitant
Psoriasis 1/1/2009 Female 194 lb 3/14/2009 Consumer United States
Primary
Concomitant
Orthostatic Hypotension 1/1/2009 Male 3/14/2009 Physician United States
Primary
Concomitant
Vessel Perforation Hospitalization 3/30/2009 Female 102 lb 4/17/2009 Canada
Primary
Concomitant
Vessel Perforation Hospitalization 3/30/2009 Female 102 lb 4/30/2009 Canada
Primary
Concomitant
Vessel Perforation Other Serious 3/30/2009 Female 102 lb 5/14/2009 Canada
Primary
Concomitant
Non-small Cell Lung Cancer Other Serious 4/17/2009 Female 126 lb 6/5/2009 United States
Primary
Concomitant
Injection Site Pain 1/1/2008 Male 240 lb 6/11/2009 Consumer United States
Primary
Concomitant
Tremor 1/1/2008 Female 175 lb 6/11/2009 Consumer United States
Primary
Concomitant
Headache 8/1/2008 Male 220 lb 6/11/2009 Physician United States
Primary
Concomitant
Skin Exfoliation 3/1/2009 Female 170 lb 6/11/2009 Consumer United States
Primary
Concomitant
Infected Cyst 1/1/2008 Male 172 lb 6/11/2009 United States
Primary
Concomitant
Scratch 1/1/2008 Female 125 lb 6/12/2009 Consumer United States
Primary
Concomitant
Injection Site Pain 10/1/2008 Female 130 lb 6/12/2009 United States
Primary
Concomitant
Rash 11/7/2008 Female 6/12/2009 United States
Primary
Concomitant
Oedema Peripheral 1/27/2009 Male 6/12/2009 Other Health Professional United States
Primary
Concomitant
Injection Site Nodule 4/17/2009 Female 115 lb 6/12/2009 United States
Primary
Concomitant
Musculoskeletal Pain 3/1/2009 Male 174 lb 6/12/2009 United States
Primary
Concomitant
Swelling 4/30/2009 Female 6/12/2009 United States
Primary
Concomitant
Skin Exfoliation Other Serious 11/1/2008 Male 210 lb 6/30/2009 Physician United States
Primary
Concomitant
Fatigue Other Serious 1/30/2009 Female 129 lb 7/23/2009 Physician United States
Primary
Secondary
Concomitant
Respiratory Tract Congestion Other Serious 1/1/2007 Female 120 lb 8/14/2009 United States
Primary
Concomitant
Osteomyelitis Other Serious 1/1/2008 Female 124 lb 8/28/2009 United States
Primary
Concomitant
Non-small Cell Lung Cancer Stage Iiib Other Serious 4/17/2009 Female 126 lb 9/18/2009 United States
Primary
Concomitant
Tremor 1/1/2008 Female 175 lb 9/18/2009 Consumer United States
Primary
Concomitant
Headache 8/1/2008 Male 225 lb 9/18/2009 Physician United States
Primary
Concomitant
Drug Dose Omission 6/1/2009 Male 256 lb 9/18/2009 United States
Primary
Concomitant
Injection Site Pain 1/1/2007 Female 115 lb 9/18/2009 United States
Primary
Concomitant
Drug Dose Omission 6/23/2009 Female 115 lb 9/19/2009 United States
Primary
Concomitant
Drug Dose Omission 6/28/2009 Female 180 lb 9/19/2009 Consumer United States
Primary
Concomitant
Oral Papilloma 6/24/2009 Male 239 lb 9/19/2009 United States
Primary
Concomitant
Weight Increased 4/1/2009 Female 215 lb 9/19/2009 United States
Primary
Concomitant
Pharyngitis Streptococcal 5/1/2009 Female 130 lb 9/19/2009 Consumer United States
Primary
Concomitant
Vomiting 6/1/2009 Female 240 lb 9/19/2009 United States
Primary
Secondary
Concomitant
Vomiting 1/1/2006 Female 165 lb 9/19/2009 United States
Primary
Concomitant
Wrong Technique In Drug Usage Process 8/7/2009 Female 175 lb 9/19/2009 Consumer United States
Primary
Concomitant
Tendonitis 8/1/2009 Female 211 lb 9/19/2009 Other Health Professional United States
Primary
Concomitant
Osteomyelitis Other Serious 1/1/2008 Female 124 lb 9/28/2009 United States
Primary
Concomitant
Intraocular Pressure Increased Other Serious 1/1/2007 Female 10/2/2009 United States
Primary
Concomitant
Transfusion Other Serious 9/1/2009 Female 124 lb 11/5/2009 Canada
Primary
Concomitant
Transfusion Other Serious 9/1/2009 Female 124 lb 11/25/2009 Canada
Primary
Concomitant
Transfusion Other Serious 9/1/2009 Female 124 lb 12/17/2009 Canada
Primary
Concomitant
Fatigue Other Serious 1/30/2009 Female 129 lb 12/21/2009 Physician United States
Primary
Secondary
Concomitant
Fatigue Other Serious 1/30/2009 Female 129 lb 12/22/2009 Physician United States
Primary
Secondary
Concomitant
Transfusion Other Serious 9/1/2009 Female 124 lb 12/23/2009 Canada
Primary
Concomitant
Tremor 1/1/2007 Female 250 lb 1/29/2010 United States
Primary
Concomitant
Periodontal Disease 1/1/2003 Male 180 lb 1/29/2010 Consumer United States
Primary
Concomitant
Drug Dose Omission 8/31/2009 Female 155 lb 1/29/2010 Consumer United States
Primary
Concomitant
Vomiting Other Serious 1/1/2008 Female 125 lb 1/29/2010 Consumer United States
Primary
Concomitant
Unevaluable Event 8/31/2009 Female 145 lb 1/29/2010 United States
Primary
Concomitant
Poor Quality Drug Administered 8/1/2009 Female 225 lb 1/29/2010 United States
Primary
Concomitant
Drug Ineffective 1/1/2009 Male 230 lb 1/29/2010 Other Health Professional United States
Primary
Concomitant
Adverse Event 9/8/2009 Female 1/29/2010 United States
Primary
Concomitant
Sensation Of Pressure 9/1/2009 195 lb 1/29/2010 United States
Primary
Concomitant
Injection Site Pain 1/1/2008 Female 279 lb 1/30/2010 Consumer United States
Primary
Concomitant
Vomiting 10/26/2009 Female 164 lb 1/30/2010 United States
Primary
Concomitant
Stress 7/30/2009 Female 141 lb 1/30/2010 United States
Primary
Concomitant
Pyrexia 11/30/2009 Female 170 lb 1/30/2010 Puerto Rico
Primary
Concomitant
Paranasal Sinus Hypersecretion 11/6/2009 Female 160 lb 1/30/2010 United States
Primary
Concomitant
Pain In Extremity 10/1/2009 Female 150 lb 1/30/2010 United States
Primary
Concomitant
Fatigue 11/9/2009 Female 310 lb 1/30/2010 United States
Primary
Concomitant
Skin Warm 11/20/2009 Female 124 lb 1/30/2010 United States
Primary
Concomitant
Abdominal Pain Upper 11/25/2009 Male 280 lb 1/30/2010 United States
Primary
Concomitant
Rash 12/1/2009 Female 168 lb 1/30/2010 United States
Primary
Concomitant
Fall 12/20/2009 Male 160 lb 1/30/2010 United States
Primary
Concomitant
Drug Ineffective 11/1/2009 Female 150 lb 1/30/2010 Consumer United States
Primary
Concomitant
Expired Drug Administered 12/29/2009 Female 145 lb 1/30/2010 Consumer United States
Primary
Concomitant
Pharyngeal Mass Other Serious 3/1/2009 Female 202 lb 2/8/2010 United States
Primary
Concomitant
Pharyngeal Mass Other Serious 3/1/2009 Female 202 lb 2/16/2010 United States
Primary
Concomitant
Vitreous Haemorrhage Other Serious 1/1/1998 Male 3/3/2010 Other Health Professional United States
Primary
Secondary
Concomitant
Vitreous Haemorrhage Other Serious 1/1/1998 46 Male 4/14/2010 Other Health Professional United States
Primary
Secondary
Concomitant
Tongue Neoplasm Other Serious 3/1/2009 58 Female 202 lb 4/15/2010 United States
Primary
Concomitant
White Blood Cell Count Decreased Disability 6/1/2007 70 Female 219 lb 4/15/2010 United States
Primary
Concomitant
Viral Load Increased Other Serious 6/25/2008 51 Female 6/11/2010 Consumer United States
Primary
Concomitant
Vomiting Hospitalization Female 124 lb 6/17/2010 Physician Canada
Primary
Concomitant
Colon Cancer Other Serious 4/12/2010 54 Male 7/12/2010 Other Health Professional United States
Primary
Concomitant
Viral Load Increased Other Serious 6/25/2008 51 Female 7/29/2010 Consumer United States
Primary
Concomitant
Oedema Peripheral Female 8/9/2010 Consumer United States
Primary
Secondary
Colon Cancer Other Serious 4/12/2010 54 Male 8/11/2010 Other Health Professional United States
Primary
Concomitant
Weight Decreased Other Serious 8/8/2010 67 Male 8/24/2010 Consumer Canada
Primary
Concomitant
Meningioma Benign Other Serious 12/1/2009 65 Male 248 lb 9/1/2010 Consumer United States
Primary
Concomitant
Weight Decreased Other Serious 8/8/2010 67 Male 9/3/2010 Physician Canada
Primary
Concomitant
Meningioma Benign Other Serious 12/1/2009 65 Male 248 lb 9/8/2010 Physician United States
Primary
Concomitant
Weight Increased Other Serious 1/1/2009 44 Female 132 lb 9/16/2010 Other Health Professional United States
Primary
Concomitant
Weight Increased 4/1/2010 61 Female 160 lb 9/17/2010 United States
Primary
Concomitant
Vitreous Haemorrhage Other Serious 1/1/1998 46 Male 10/1/2010 Other Health Professional United States
Primary
Secondary
Concomitant
Skin Burning Sensation Hospitalization 1/1/2007 68 Female 150 lb 11/4/2010 Consumer United States
Primary
Concomitant
Skin Burning Sensation Hospitalization 1/1/2007 68 Female 150 lb 11/9/2010 Consumer United States
Primary
Concomitant
Scar Other Serious 10/1/2010 66 Female 162 lb 12/10/2010 Consumer United States
Primary
Concomitant
Type 2 Diabetes Mellitus Other Serious 10/1/2010 68 Male 12/10/2010 Physician United States
Primary
Concomitant
Scar Other Serious 10/1/2010 66 Female 162 lb 12/15/2010 Consumer United States
Primary
Concomitant
Type 2 Diabetes Mellitus Other Serious 10/1/2010 68 Male 12/17/2010 Physician United States
Primary
Concomitant
Dry Mouth Other Serious 1/1/2006 65 Female 170 lb 1/7/2011 Other Health Professional United States
Primary
Concomitant
Chronic Obstructive Pulmonary Disease Hospitalization 12/1/2010 60 Female 170 lb 1/28/2011 Consumer United States
Primary
Concomitant
Influenza 4/23/2010 53 Female 145 lb 1/28/2011 United States
Primary
Concomitant
Contusion 1/1/2009 66 Female 1/28/2011 United States
Primary
Concomitant
Inflammatory Bowel Disease 1/1/2008 42 Female 175 lb 1/28/2011 Physician United States
Primary
Concomitant
Headache 8/1/2008 32 Male 215 lb 1/28/2011 United States
Primary
Concomitant
Arthralgia 3/29/2010 65 Male 1/28/2011 United States
Primary
Concomitant
Tremor 1/14/2010 34 Male 184 lb 1/28/2011 United States
Primary
Concomitant
Oedema Peripheral Female 1/28/2011 Consumer United States
Primary
Secondary
Incorrect Dose Administered Male 165 lb 1/28/2011 United States
Primary
Concomitant
Blood Alkaline Phosphatase Increased 1/1/2010 55 Female 150 lb 1/28/2011 Physician United States
Primary
Concomitant
Fall 4/1/2010 48 Male 1/28/2011 Consumer United States
Primary
Concomitant
Unevaluable Event Male 1/28/2011 Pharmacist United States
Primary
Concomitant
Nightmare 2/1/2010 59 Female 150 lb 1/28/2011 United States
Primary
Concomitant
Nightmare 4/14/2010 59 Female 159 lb 1/28/2011 Consumer United States
Primary
Concomitant
Pain Female 145 lb 1/28/2011 Consumer United States
Primary
Concomitant
Injection Site Haematoma 1/1/2007 34 Female 185 lb 1/28/2011 Consumer United States
Primary
Concomitant
Injection Site Haematoma 3/31/2010 55 Female 141 lb 1/28/2011 Consumer United States
Primary
Concomitant
Sinusitis Other Serious 1/1/2009 65 Female 200 lb 1/28/2011 United States
Primary
Concomitant
Gait Disturbance 1/1/2010 46 Female 152 lb 1/28/2011 Consumer United States
Primary
Concomitant
Drug Effect Decreased 1/1/2005 20 Male 175 lb 1/29/2011 Consumer United States
Primary
Concomitant
Asthenia 66 Male 1/29/2011 Consumer United States
Primary
Concomitant
Rash Papular 68 Female 1/29/2011 Consumer United States
Primary
Concomitant
Eczema 1/1/2009 51 Female 1/29/2011 Consumer United States
Primary
Concomitant
Hypoaesthesia 6/1/2009 50 Female 1/29/2011 Physician United States
Primary
Concomitant
Abdominal Discomfort 4/15/2010 59 Female 159 lb 1/29/2011 Physician United States
Primary
Secondary
Concomitant
Injection Site Haemorrhage 6/6/2010 Female 1/29/2011 Consumer United States
Primary
Concomitant
Fatigue 6/8/2010 69 Female 1/29/2011 Consumer United States
Primary
Concomitant
Heart Rate Increased 6/7/2010 63 Female 1/29/2011 Other Health Professional United States
Primary
Concomitant
Arthralgia 6/28/2010 66 Male 1/29/2011 Consumer United States
Primary
Concomitant
Injection Site Papule 7/26/2010 58 Male 1/29/2011 Consumer United States
Primary
Concomitant
Hypoaesthesia 6/18/2010 38 Female 1/29/2011 Consumer United States
Primary
Concomitant
Vomiting 5/1/2010 58 Female 1/29/2011 Consumer United States
Primary
Concomitant
Injection Site Haematoma 7/1/2010 66 Female 255 lb 1/29/2011 Consumer United States
Primary
Concomitant
Abdominal Pain Other Serious 7/1/2010 50 Female 1/29/2011 Consumer United States
Primary
Concomitant
Injection Site Vesicles 2/1/2010 21 Female 1/29/2011 Consumer United States
Primary
Concomitant

Drug Data